Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemia.

Leukemia · 2026 · PMC12875880 · PMID 41507381

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

We found a significant enrichment for fusion-positive M7 AML and a borderline significant enrichment for fusion-positive non-M7 AML (Supplementary Fig. 4A, B ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.